Arcadia Biosciences (RKDA) Stock Overview
Produces and markets plant-based food and beverage products in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
RKDA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Arcadia Biosciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.62 |
| 52 Week High | US$10.31 |
| 52 Week Low | US$2.40 |
| Beta | 0.52 |
| 1 Month Change | 19.38% |
| 3 Month Change | 32.75% |
| 1 Year Change | 58.89% |
| 3 Year Change | -91.18% |
| 5 Year Change | -97.16% |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Zola Distribution Expansion Will Unlock Enduring Market Strength
Arcadia's focus on expanding Zola distribution and profitable product lines is set to drive revenue growth and improve earnings through high-margin sales.We're Hopeful That Arcadia Biosciences (NASDAQ:RKDA) Will Use Its Cash Wisely
Mar 01
Arcadia Biosciences to raise $5M in securities offering
Aug 15Arcadia Biosciences: Market Still Unconvinced Of Its Health Offerings
Nov 29We Think Shareholders Should Be Aware Of Some Factors Beyond Arcadia Biosciences' (NASDAQ:RKDA) Profit
Nov 22Shareholder Returns
| RKDA | US Food | US Market | |
|---|---|---|---|
| 7D | 0.4% | 0.3% | 1.4% |
| 1Y | 58.9% | -9.2% | 11.6% |
Return vs Industry: RKDA exceeded the US Food industry which returned -9.5% over the past year.
Return vs Market: RKDA exceeded the US Market which returned 12.6% over the past year.
Price Volatility
| RKDA volatility | |
|---|---|
| RKDA Average Weekly Movement | 11.3% |
| Food Industry Average Movement | 5.5% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: RKDA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RKDA's weekly volatility has decreased from 19% to 11% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 9 | Thomas Schaefer | www.arcadiabio.com |
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Arcadia Biosciences, Inc. Fundamentals Summary
| RKDA fundamental statistics | |
|---|---|
| Market cap | US$6.30m |
| Earnings (TTM) | -US$771.00k |
| Revenue (TTM) | US$5.26m |
Is RKDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RKDA income statement (TTM) | |
|---|---|
| Revenue | US$5.26m |
| Cost of Revenue | US$3.07m |
| Gross Profit | US$2.19m |
| Other Expenses | US$2.96m |
| Earnings | -US$771.00k |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.56 |
| Gross Margin | 41.69% |
| Net Profit Margin | -14.66% |
| Debt/Equity Ratio | 0% |
How did RKDA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/04 12:51 |
| End of Day Share Price | 2025/06/04 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arcadia Biosciences, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Klieve | Lake Street Capital Markets, LLC |
| Jon Ritzenthaler | Piper Sandler Companies |
| Brett William Wong | Piper Sandler Companies |